Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer
Status:
Completed
Trial end date:
2001-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Amifostine may
protect normal cells from the side effects of radiation therapy.
PURPOSE: Phase II trial to study the effectiveness of radiation therapy plus amifostine in
treating patients with primary prostate cancer.